Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Teva Pharmaceutical Industries ADR (NY: TEVA ) 16.98 +0.17 (+1.01%) Official Closing Price Updated: 6:30 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 6,213,791 Open 16.78 Bid (Size) 16.62 (1) Ask (Size) 17.08 (1) Prev. Close 16.81 Today's Range 16.78 - 17.18 52wk Range 8.055 - 17.69 Shares Outstanding 1,110,352,397 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why Hims & Hers Heath Shares Are Surging Today Today 15:23 EDT Hims & Hers Health Inc. (NYSE: HIMS) shares are moving higher on Monday amidst the announcement of Kåre Schultz's appointment to the Board of Directors. Via Benzinga $100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today July 19, 2024 Via Benzinga Performance YTD +59.14% +59.14% 1 Month +0.12% +0.12% 3 Month +31.83% +31.83% 6 Month +47.78% +47.78% 1 Year +96.53% +96.53% More News Read More Teva's Migraine Treatment Found Effective For Children As Young As 6 July 18, 2024 Via Benzinga Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY® (fremanezumab) SPACE Trial for Prevention of Episodic Migraine July 18, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There' July 17, 2024 Via Benzinga Breaking Down Teva Pharmaceutical Indus: 5 Analysts Share Their Views June 27, 2024 Via Benzinga If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today June 12, 2024 Via Benzinga 3 No-Brainer Stocks to Buy With $200 Right Now July 17, 2024 Via The Motley Fool Here's How Much $1000 Invested In Teva Pharmaceutical Indus 5 Years Ago Would Be Worth Today July 16, 2024 Via Benzinga Teva Pharmaceuticals Stock: Unlock Value in This Generic Drug Gem July 10, 2024 Via MarketBeat Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024 July 02, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire 4 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know May 30, 2024 Via Benzinga FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse July 01, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Dr. Reddy's Labs Stock Sees Improved Technical Strength June 28, 2024 Via Investor's Business Daily New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses June 28, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020 June 25, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States June 24, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire Teva Engages In Settlement Talks Over Medicare Kickback Allegations June 18, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know June 14, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal 7 A-Rated Biotech Stocks Worth Betting on in June June 14, 2024 Via InvestorPlace What is a Bull Flag Pattern? Explanation and Examples June 13, 2024 Via MarketBeat Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference June 04, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate) June 01, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024 June 01, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire 2 Generic Drug Makers With Growing Runways May 31, 2024 Via MarketBeat Topics Intellectual Property Exposures Intellectual Property Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
